The Paradigm Peptides Case: What the Court Record Established, and What It Never Showed
A lot of claims are circulating about the Paradigm Peptides case. Some come from the court record, some from media reporting, and some from vendors using the case to sell their own products. Those three are not equal.
This article sorts them out, helping you distinguish established facts from reported claims and from what remains unknown.
1. Established Facts (from the Department of Justice)
The following comes from official U.S. Department of Justice records and counts as established fact:
First, both defendants pleaded guilty. Matthew Kawa and Jennifer Stechkober pleaded guilty in December 2025.
Second, the sentences. Kawa received 70 months, and Stechkober received 16 months, each followed by one year of supervised release.
Third, the money judgment. The court entered a $5 million money judgment against Kawa.
Fourth, restitution. The two defendants owe $78,317.52 in restitution, jointly.
Fifth, customer scale. Between 2019 and 2024, they sold to more than 54,000 customers in all 50 states and more than 80 countries, for about $5 million.
Sixth, product adulteration. Many SARMs were actually testosterone, not the compound on the label.
Seventh, warning letters. The FDA sent warning letters to Paradigm in 2020 and 2022.
2. Reported from Court Filings
The following comes from media reporting citing court filings. These are reported but not directly established in Department of Justice statements:
First, all six SARM products the government tested contained testosterone (CBS News, citing prosecutors).
Second, certificates of analysis were forged (CBS News and BBC, citing the pleas).
Third, the FDA seized SARM products for testing by September 2023 (BBC).
Fourth, 167 victims came forward for restitution (BBC).
These have clear media sources, but they are not facts directly listed by the Department of Justice in official statements.
3. What Has Not Been Established
This is the most important part of this article.
As of now, no public document reports what was actually in Paradigm's peptide vials.
The peptides were charged as unapproved new drugs, and they were sold with the same forged paperwork and the same absence of testing. But no public document states what the vials contained.
Untested is not the same as contaminated. It means nobody knows, and that includes the person who sold it.
4. Why This Distinction Matters
Many people see this case and immediately conclude "peptides were contaminated." But the court record does not support that conclusion.
The proven adulteration was in SARM pills, not in peptide vials.
This distinction matters because it determines how you judge the market:
If you believe "peptides were contaminated," you may conclude "all peptides are dangerous."
If you understand "peptides were untested," you reach a more accurate conclusion: the risk is not known contamination, but unknown contents.
5. How Vendors Are Using This Case
Some vendors are using this case to market their own products. The pitch usually goes:
"You see, Paradigm got caught, so you should buy from us — we have certificates."
But the problem is this: Paradigm's customers also saw certificates. The certificates were forged.
So merely claiming "we have certificates" proves nothing. What matters is whether the certificate can be independently verified.
6. How to Verify a Certificate of Analysis
Treat a certificate as a claim to be checked, not as proof. Here is what checking looks like:
First, verify it with the lab, not the vendor. A certificate names a laboratory and a report number. Contact the lab or use its lookup page.
Second, match the batch. The lot number on the certificate should match the lot number on your vial.
Third, look at what was tested. Purity and identity are two tests. Sterility and endotoxin are two more. Most vendor certificates cover only the first two.
Fourth, be suspicious of identical numbers. The same 99% figure on every product is a marketing line, not a measurement.
Fifth, check what other buyers found. Independent testing paid for by customers is harder to forge than a vendor's own paperwork.
7. Summary
The Paradigm Peptides case record can be summarized as follows:
First, established facts: guilty pleas, sentences, money judgment, restitution, customer scale, SARM adulteration, warning letters.
Second, reported facts: six SARMs contained testosterone, forged certificates, FDA seizure and testing, 167 victims.
Third, what has not been established: the contents of the peptide vials.
Understanding this distinction helps you view this case more rationally, and helps you judge whether vendor marketing that borrows this case is credible.
Frequently Asked Questions
Were Paradigm's peptides contaminated?
That has not been established publicly. The proven adulteration was testosterone in SARM products. The peptides were sold untested and with forged certificates, so their contents are unknown.
What is the difference between "untested" and "contaminated"?
Untested means nobody knows what the contents are; contaminated means a harmful substance has been proven to be present. The former is unknown, the latter is a proven risk.
Is it credible when a vendor says "we have certificates"?
You cannot rely on that statement alone. Paradigm's customers also saw certificates, but the certificates were forged. What matters is whether the certificate can be independently verified.
How can I tell if a certificate is real?
Confirm the report directly with the laboratory named on it, and check that the batch number matches your vial. A certificate you cannot verify with the lab should be treated as unverified.